Guggenheim Maintains Buy on Exelixis, Raises Price Target to $42

Benzinga · 01/07 16:51
Guggenheim analyst Michael Schmidt maintains Exelixis (NASDAQ:EXEL) with a Buy and raises the price target from $33 to $42.